We are live on ! Find out more
MRNY icon

YieldMax MRNA Option Income Strategy ETF
MRNY

3 hedge funds and large institutions have $901K invested in YieldMax MRNA Option Income Strategy ETF in 2023 Q4 according to their latest regulatory filings, with 3 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

0.06% more ownership

Funds ownership: 0% → 0.06% (+0.06%)

Holders
3
Holders Change
+3
Holders Change %
–
% of All Funds
0.04%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
OMC
Old Mission Capital
Illinois
+$432K
2
UBS Group
UBS Group
Switzerland
+$3.17K

Top Sellers

No sellers this quarter

MRNY Hedge Fund Activity: Q4 2023 in Review

3 of the 6,872 institutional investors tracked by Wall St. Rank reported a position in YieldMax MRNA Option Income Strategy ETF (MRNY) for Q4 2023, worth a combined $901K.

Buyers outnumbered sellers: 3 funds opened new MRNY positions and 0 closed out — a net gain of 3 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Old Mission Capital, opening a new position worth an estimated $432K.

  • 3 institutional investors held YieldMax MRNA Option Income Strategy ETF (MRNY) as of Q4 2023, up from 0 in Q3 2023.
  • Funds reported $901K of YieldMax MRNA Option Income Strategy ETF stock for Q4 2023.
  • 3 funds opened new YieldMax MRNA Option Income Strategy ETF positions in Q4 2023 and 0 closed out, a net change of +3 holders.
  • The largest YieldMax MRNA Option Income Strategy ETF buyer in Q4 2023 was Old Mission Capital, an estimated $432K added.

Based on aggregated 13F filings for Q4 2023.